People in the News

Premium

Fluidigm said this week that Patrick Jones has been appointed to the company's board of directors and will chair the board's audit committee.

Jones has been a private investor in Fluidigm since March 2001. He currently sits on the boards of several public companies, including Epocrates, Novell, Lattice Semiconductor, and Openwave Systems.

Jones fills a vacancy created by the resignation of Jeremy Loh, who is a vice president of investments at San Francisco Centre for EDB Investments in Singapore.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.